R&D Roundup: Novartis pipeline, CRISPR funding and Opdivo disappointmentsNovartis has showcased its pipeline at its annual meet-the-management day, where investors and analysts got to hear company Share XR&D Roundup: Novartis pipeline, CRISPR funding and Opdivo disappointmentshttps://pharmaphorum.com/views-and-analysis/rd-roundup-novartis-crispr-opdivo/
Digital therapeutics start-ups need patience as well as patientsAn entirely new category of medicine is emerging, and a new wave of digital therapeutics start-ups is joining Share XDigital therapeutics start-ups need patience as well as patientshttps://pharmaphorum.com/views-analysis-digital/bayer-g4a-digital-therapeutics-startups/
Adapting for successThe last two decades have seen often limited treatment options for cancers give way to therapies with increasingly Share XAdapting for successhttps://pharmaphorum.com/views-and-analysis/cancer-clinical-trials-tracon-cytel/
The top 10 ways digital will transform healthcareJanssen’s Kris Sterkens gives his thoughts on how digital will continue to influence healthcare in the age of Share XThe top 10 ways digital will transform healthcarehttps://pharmaphorum.com/views-analysis-digital/the-top-10-ways-digital-will-transform-healthcare/
Digital health goes global and continues to grow upHow to deal with new and emerging technologies is an ongoing problem for healthcare stakeholders, who often struggle Share XDigital health goes global and continues to grow uphttps://pharmaphorum.com/digital/digital-health-guidelines-growth/
Patient Insights: Severe psoriasis & eczemaHoward Chang has lived with severe psoriasis and atopic dermatitis for almost 40 years since childhood. Now a Share XPatient Insights: Severe psoriasis & eczemahttps://pharmaphorum.com/views-analysis-patients/patient-insights-severe-psoriasis-eczema/
Oncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and moreAZ and Daiichi Sankyo announced positive top-line results from the pivotal phase 2 DESTINY-Breast01 trial of trastuzumab deruxtecan, Share XOncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and morehttps://pharmaphorum.com/views-and-analysis/oncology-round-up-az-and-daiichi-score-key-trial-win-with-breast-cancer-antibody-and-more/
US healthcare reform scenarios and their impact on the systemIn an effort to control healthcare costs, provide healthcare to the uninsured and underinsured, and improve health outcomes, Share XUS healthcare reform scenarios and their impact on the systemhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/icon-us-healthcare-reform-scenarios/
Customer experience performance by pharmaceutical companiesThe need for pharmaceutical companies to meet or, ideally exceed, the expectations their customers have of them is Share XCustomer experience performance by pharmaceutical companieshttps://pharmaphorum.com/views-and-analysis/pharmaceutical-customer-experience-performance/
